Signaling pathway reveals mechanism for B cell differentiation in immune response

27-Apr-2011 - An article in Science Signaling by researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) has clarified for the first time the mechanism governing differentiation of B cells into antibody-producing plasma cells. The finding establishes a role for the extracellular ...

New study sheds light on evolution of 2009 pandemic influenza A(H1N1) virus in Japan

27-Apr-2011 - Analysis of mutations of the 2009 pandemic influenza A(H1N1) virus by researchers at the RIKEN Omics Science Center (OSC) has revealed major genetic differences between the virus in its early phase of infection in Japan and in its peak phase. While yielding valuable clues on the genetic origins ...

Eisai: Halaven Receives Approval in Japan for the Treatment of Inoperable and Recurrent Breast Cancer

26-Apr-2011 - Eisai Co., Ltd. announced that it has received approval to market its anticancer Halaven(R) Injection 1mg (eribulin mesylate) in Japan for the treatment of inoperable and recurrent breast cancer. Discovered and developed by Eisai, Halaven is now approved in each of the world's three largest ...

Nitto Denko Acquires Avecia Biotechnology

10-Feb-2011 - Nitto Denko Corporation announced that it has acquired Avecia Biotechnology, Inc. through Nitto Americas, Inc., a wholly owned subsidiary in Teaneck, New Jersey.Located in Milford, Massachusetts, Avecia Biotechnology provides nucleic acid manufacturing and development services. Avecia provides ...

The Trap Snaps Shut

Researchers isolate the substance that causes Venus flytraps to close

11-Nov-2010 - The Venus flytrap is a carnivorous plant luring insect prey with drops of liquid. The trap snaps shut like a steel jaw when an insect touches one of the very fine hairs within. The prey is caught – digestion begins. Minoru Ueda and a research team from the Universities of Tohoku, Hirosaki, and ...

Takeda Announces Top Line Results from Phase 2 Study of Investigational Compound, TAK-442 for the patients with ACS

28-Oct-2010 - Top line data from a phase 2 study of TAK-442, an oral anticoagulant, biologically active factor Xa inhibitor (fXai), under investigation by Takeda, are now available. This phase 2, multi-center, randomized double blind, placebo-controlled study conducted globally except in Japan was designed to ...

Epistem Announce Agency Agreement With Veritas Japan

03-Sep-2010 - Epistem plc announced that its Contract Research Services division has entered into an agreement with the Veritas Corporation to exclusively market and distribute Epistem's scientific research services in Japan. The Veritas agreement will provide Epistem with a sales and marketing presence in ...

Novartis awards 2010 Prizes for Immunology in recognition of outstanding contributions to immunology in medical research

25-Aug-2010 - The Novartis 2010 Immunology Prizes were presented at the 16th International Congress of Immunology in Kobe, Japan. Since 1992, the Novartis Prizes for Immunology have been awarded every third year for outstanding contributions to basic and clinical immunology. The prizes recognize individual ...

Key Patent of Protagen Granted in Japan

13-Aug-2010 - Protagen AG announced that it received a Notice of Allowance by the Japanese Patent Office stating a favourable decision for the patent application 2000-547262 developed at the Max-Planck Institute for Molecular Genetics in Berlin, Germany. This patent claims broadly a method for identifying and ...

Proteros achieves growth rate of more than 30 % in 2009 and announces expansion of commercial organization in USA and Japan

06-Aug-2010 - Proteros confirmed its annual financial statement for 2009, which showed a growth rate, in revenues, in excess of 30% while maintaining profitability. In order to continue achieving high and profitable growth, for its structure guided drug discovery services, Proteros announced that it has ...